메뉴 건너뛰기




Volumn 282, Issue 5 51-5, 2002, Pages

Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis

Author keywords

Cytokines; Oxyradical; Shock

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE DEAMINASE; ADENOSINE RECEPTOR BLOCKING AGENT; CYTOKINE; ESCHERICHIA COLI ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; PENTOSTATIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

EID: 0036089180     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00373.2001     Document Type: Article
Times cited : (61)

References (39)
  • 4
    • 0027422366 scopus 로고
    • Pentostatin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders
    • (1993) Drugs , vol.46 , pp. 652-677
    • Brogden, R.N.1    Sorkin, E.M.2
  • 16
    • 0005926487 scopus 로고    scopus 로고
    • Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome. US Patent 6,103,702. 15 Aug. 2000. Int. Cl. A61K 031/70
    • Law, W.R.1
  • 32
    • 0026718311 scopus 로고
    • Effect of adenosine analogues and cAMP-raising agents on TNF-, GM-CSF-, and chemotactic peptide-induced degranulation in single adherent neutrophils
    • (1992) J Leukoc Biol , vol.51 , pp. 270-275
    • Richter, J.1
  • 39
    • 0026008442 scopus 로고
    • Adenine nucleotide changes in kidney, liver, and small intestine during different forms of ischemic injury
    • (1991) Circ Res , vol.68 , pp. 185-196
    • Zager, R.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.